Home » Topics » Regulatory » EMA

EMA
RSS

European CHMP hands down negative opinion for Raxone MAA

Jan. 18, 2013

FDA and EMA to review GE Healthcare's applications for flutemetamol (18F)

Jan. 10, 2013

European orphan drug designation recommended for VAL-083 for glioma

Jan. 8, 2013

EMA accepts MAA for aripiprazole depot formulation

Dec. 24, 2012

Intercell obtains positive CHMP opinion for pediatric use of its JE vaccine

Dec. 20, 2012

Roche's Perjeta receives CHMP recommendation for approval

Dec. 18, 2012

Alexza's MAA for Adasuve receives positive opinion from EMA advisory committee

Dec. 18, 2012

EMA committee recommends approval of Selincro for alcohol dependence

Dec. 17, 2012

Vanda's Fanaptum receives negative opinion from EMA

Dec. 17, 2012

EMA committee adopts negative opinion on MAA for Kynamro in HoFH

Dec. 17, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...